A hospital acquired infection (HAI) or nosocomial infection or health care associated
infection (HAI or HCAI), is an infection that is acquired in a health care facility. The infection
acquired in health care facility by a patient must be other than the one for which the patient
was admitted and includes infections acquired in the hospital however effects and symptoms
appear after discharge. The HAI also includes occupational infection among staff of the
hospital.
The Global Hospital Acquired Infections Market was $23.7 billion in 2016 and is
expected to reach around $36.16 billion by the end of the forecast period growing at a
CAGR of 7.3%.
The infection can originate from outside environment, another infected patient, or from staff
that may be infected; in some cases, the source of the infection cannot be determined.
There are cases where microorganism originates from the patient's own skin micro biota,
becoming opportunistic after surgery or other procedures that compromise the protective
skin barrier. WHO estimates that 8.7% of hospital patients had nosocomial infections
affecting over 1.4 million people worldwide.
The market’s driving factors are nature and virulence of the microbial agent, patient
susceptibility such as immunity, presence of other diseases, environmental factors such as
infected materials and bacterial load in hospitals, crowding, temperature and humidity etc.,
bacterial resistance to drugs, the age of patient., high prevalence of HAI, lack of awareness,
poor training and infection control practices, poor hospital infrastructure and regulation, low
expenditure on healthcare, rise of chronic diseases with prolonged stay in hospitals etc.
Get Sample Copy at http://bit.ly/2pKxqGH .
The market restraints are growth of microbial resistance, spurious and counterfeit products,
off label use of antiseptics and drugs, rise of disposables, increasing use of quality
construction material such as ceramics and glass in buildings, huge fragmentation of market
& number of players, loss of patents & great penetration of generics etc. The technology
advancement in the form of gas plasma sterilization technology will drive the future global
HAI market.
Intended Audience
Hospital acquired infections control drugs and instruments manufacturers
Hospital acquired infections control drugs suppliers
Private research laboratories
Research and development (R&D) companies
Market research and consulting service providers
Government research laboratories
Contract manufacturing organizations
Key Players for Global Hospital-acquired infections Market: Advanced Sterilization Products,
3M Company, Becton Dickinson and company, STERIS Corporation, Getinge AB, Cantel
Medical Corp., Belimed AG, and others.
Segments: